Second-generation Radiofrequency Application and Therapeutic Exercise for Stress Urinary Incontinence
Launched by CARDENAL HERRERA UNIVERSITY · Jul 24, 2025
Trial Information
Current as of August 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying new ways to treat stress urinary incontinence (SUI), a condition where women accidentally leak urine during activities like coughing, sneezing, or exercising because of pressure on the bladder. The study is looking at two treatments: radiofrequency (RF) therapy, which uses gentle energy to help strengthen and repair tissues, and pelvic floor muscle exercises, which help improve the muscles that support the bladder. Researchers want to see if using RF alone, exercises alone, or a combination of both works best to reduce leakage and improve quality of life.
Women over 18 who experience urine leakage during physical activities but don’t have other bladder problems may be eligible to join. Participants will receive one or both treatments at a specialized clinic in Costa Rica and will be followed for a year to check how well the treatments improve muscle strength, bladder function, and daily life. The treatments are non-invasive (no surgery) and painless, making them a gentle option for women looking to manage SUI. Women who have other urinary conditions, recent pelvic surgery, infections, or certain medical issues won’t qualify for this study.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women over the age of 18 who meet the International Continence Society (ICS)
- • diagnostic criteria for SUI, which consists of involuntary leakage of urine during increased intra-abdominal pressure in the absence of bladder contractions such as coughing, sneezing, and other physical activities.
- Exclusion Criteria:
- • diagnosis of urgent or mixed UI
- • diagnosis of pelvic organ prolapse
- • taking any treatment for UI
- • pregnancy
- • history of pelvic surgery, urinary tract infection, or diagnosed psychological disorders
- • presence of scars, malformations, abnormal pelvic masses, tissue irritation, or any other condition in the area that could be causing pelvic and urinary function problems
About Cardenal Herrera University
Cardenal Herrera University is a leading academic institution dedicated to advancing healthcare research and education. With a strong emphasis on interdisciplinary collaboration, the university fosters innovative clinical trials aimed at improving patient outcomes and enhancing medical practices. Its commitment to ethical research practices, coupled with a robust network of healthcare professionals and researchers, positions Cardenal Herrera University as a key contributor to the development of evidence-based solutions in the medical field. Through its clinical trial sponsorship, the university aims to bridge the gap between research and clinical application, ultimately benefiting the broader healthcare community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Elche, Alicante, Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported